![Joshua Ziel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joshua Ziel
Amministratore Delegato presso Aerami Therapeutics, Inc.
Profilo
Joshua Ziel is currently the Chief Executive & Operating Officer at Aerami Therapeutics, Inc. He holds a doctorate degree from Duke University and an undergraduate degree from the University of Michigan.
Posizioni attive di Joshua Ziel
Società | Posizione | Inizio |
---|---|---|
Aerami Therapeutics, Inc.
![]() Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Amministratore Delegato | 01/06/2023 |
Formazione di Joshua Ziel
Duke University | Doctorate Degree |
University of Michigan | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Aerami Therapeutics, Inc.
![]() Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Health Technology |
- Borsa valori
- Insiders
- Joshua Ziel